About 2,190 results
Targeted Oncology - Immunotherapy, Biomarkers, and Cancer …
Adjuvant T-DM1 Continues to Outperform Trastuzumab in HER2 …
Managing Chemotherapy Toxicities for Improved Patient Outcomes
Treatment Strategies to Optimize Outcomes With Brentuximab …
FDA ODAC Votes Yes on Imetelstat for Patients with MDS
Early-Stage NSCLC DFS Improved with Adjuvant Atezolizumab
FDA Lifts Partial Clinical Hold on Study of Odronextamab in FL and …
FDA Approves Non-Alcohol Formulation of Docetaxel for Multiple …
Predictors of Recurrence in Ovarian Cancer - Targeted Oncology
NCCN Updates Breast Cancer Guidelines to Include Goserelin